Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The role of primary care in response to the global liver disease syndemic: a Lancet Gastroenterology & Hepatology Commission.

The lancet. Gastroenterology & hepatology·2026

Same author

A Single-Food Substitution Strategy (SFSS) Improves Fat Mass and Metabolic Parameters in MASLD: A Prospective Pilot Study.

Nutrients·2026

Same author

Eros and Thanatos of the new millennium: reflections on the relationship between a young man with Asperger's syndrome and an AI chatbot from the Italian forensic medical perspective.

La Clinica terapeutica·2026

Same author

Living with the Dead: Mad or Bad? Five paradigmatic cases of unprocessed grief.

La Clinica terapeutica·2026

Same author

Expectations and unmet needs for the post-COVID era reform of Italian primary care. Comparative perspectives across Europe and messages to the whole medicine community.

Internal and emergency medicine·2026

Same author

The emerging problem of digital and self misuse of obesity management medications: Protecting their clinical value.

European journal of clinical investigation·2026

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Published on: September 16, 2020

Mitochondria in chronic liver disease.

Ignazio Grattagliano¹, Stefan Russmann, Cátia Diogo

¹Department of Internal and Public Medicine, University Medical School, Bari, Italy.

Current Drug Targets

|January 29, 2011

Summary

Mitochondria are vital for liver cell energy and function. Impaired mitochondrial function contributes to liver disease development and progression, highlighting their role in hepatocyte injury.

More Related Videos

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Published on: August 27, 2015

Related Experiment Videos

Last Updated: Jun 4, 2026

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Published on: September 16, 2020

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Published on: August 27, 2015

Area of Science:

Hepatology
Mitochondrial Biology
Cellular Metabolism

Background:

Mitochondria are central to hepatocyte energy production and oxidative metabolism.
Their crucial role positions them at the nexus of signaling pathways involved in liver injury.
Dysfunctional mitochondria are implicated in the pathogenesis of numerous chronic liver diseases.

Purpose of the Study:

To review the role of mitochondrial dysfunction in liver diseases.
To highlight the diagnostic and prognostic potential of assessing mitochondrial function in hepatocytes.
To underscore the relevance of mitochondrial function in evaluating therapeutic strategies for liver conditions.

Main Methods:

Review of literature on mitochondrial function in various liver diseases.
Analysis of documented changes in mitochondrial structure and function.
Discussion of the impact of mitochondrial impairment on hepatocyte survival and liver disease progression.

Main Results:

Altered mitochondrial function, including electron transport chain and oxidative phosphorylation impairment, is observed in diverse liver diseases.
Consequences include reduced ATP synthesis, decreased oxidative metabolism, and diminished hepatocyte resilience.
Structural changes like swelling and matrix inclusions often accompany functional deficits.

Conclusions:

Mitochondrial dysfunction is a common feature across various chronic liver diseases.
Assessing mitochondrial function in vivo offers valuable diagnostic and prognostic insights.
Monitoring mitochondrial health is crucial for developing and evaluating novel therapeutic interventions for liver diseases.